Pandemrix pack

EMA to assess GSK flu vaccine for narcolepsy link

September 1, 2010
Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …

Pharma and the iPhone: there’s an app for that

September 1, 2010
Medical Communications, Research and Development, Sales and Marketing ipad, iphone

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …

Kendle appoints Mark Roseman chief marketing officer

September 1, 2010
Research and Development Kendle, appointment, research and development

Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …

Talking R&D: Strategic vs full service CRO

September 1, 2010
Research and Development CRO, Talking Point, Talking R&D

CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …

Roche building

Roche coy on job cut reports

September 1, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …

Paul Phull joins PharmaVentures

August 31, 2010
Sales and Marketing PharmaVentures, appointment, sales and marketing

Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …

Swiss approval for Novartis’ Tasigna

August 31, 2010
Sales and Marketing Novartis, Tasigna, Tekamlo

Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …

Lonza buys Vivante to get bigger in biologics

August 31, 2010
Manufacturing and Production Lonza, Vivante

Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …

Swiss API manufacturer opens high-potency plant

August 31, 2010
Manufacturing and Production API, Cerbios-Pharma

Cerbios-Pharma SA of Switzerland has officially opened its new high-potency active pharmaceutical ingredient manufacturing plant in Barbengo, a district in …

Hyaluron pulled up over particle contamination

August 31, 2010
Manufacturing and Production Hyaluron, manufacturing compliance

US manufacturer Hyaluron has been sent a warning letter by the FDA after a routine inspection uncovered concerns with aseptic …

SOCMA welcomes US law easing raw material imports

August 27, 2010
Manufacturing and Production Obama, SOCMA

US President Barack Obama has signed into law the Manufacturing Enhancement Act of 2010, designed to do away with import …

Chandler Chicco expands European services with Wright appointment

August 27, 2010
Medical Communications Chandler Chicco, Cohn & Wolfe, Europe

Chandler Chicco has appointed Alison Wright to a newly created post to help increase the agency’s European and global services …

US prescription drug prices rise above inflation

August 27, 2010
Sales and Marketing US, prices

A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …

US court bars stem cell funding

August 26, 2010
Sales and Marketing Obama, Stem cells, US

A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …

CMC Bio unveils disposable biomanufacturing facility

August 26, 2010
Manufacturing and Production CMC Biologics, disposables

Contract manufacturer CMC Biologics has completed the construction of a new manufacturing facility at its site in Bothell near Seattle …

J&J chalks up ninth product recall in 2010

August 26, 2010
Manufacturing and Production J&J, JJ

 Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …

Alcon acquisition makes Novartis eyecare leader

August 26, 2010
Sales and Marketing Novartis, ophthalmology

Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …

Velcade

Janssen to appeal against Velcade decision

August 26, 2010
Medical Communications, Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma

Celgene’s Thalidomide has been recommended by NICE for multiple myeloma ahead of Janssen-Cilag’s Velcade. A final appraisal determination says that …

NICE updates guidance for arthritis treatments

August 26, 2010
Sales and Marketing NICE, Roche, rheumatoid arthritis

Five new drugs for rheumatoid arthritis have been given the thumbs up by NICE as second line treatment. Roche’s MabThera, …

The Gateway to Local Adoption Series

Latest content